Cargando…
New therapeutics for traumatic brain injury : prevention of secondary brain damage and enhancement of repair and regeneration /
"New Therapeutics for Traumatic Brain Injury: Prevention of Secondary Brain Damage and Enhancement of Repair and Regeneration explores traumatic brain injury (TBI), a major cause of death and disability throughout the world. The delayed nature of the secondary injury phase suggests that there i...
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
London :
Academic Press is an imprint of Elsevier,
[2017]
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_ocn959618098 | ||
| 003 | OCoLC | ||
| 005 | 20231120112140.0 | ||
| 006 | m o d | ||
| 007 | cr |n||||||||| | ||
| 008 | 160930t20172017enka ob 001 0 eng d | ||
| 040 | |a N$T |b eng |e rda |e pn |c N$T |d N$T |d IDEBK |d OPELS |d YDX |d OCLCF |d COO |d OCLCQ |d Z5A |d OCLCO |d MERER |d OCLCO |d OCLCQ |d U3W |d D6H |d MMU |d TMC |d OCLCO |d BUF |d CASUM |d OCLCO |d GWM |d UIU |d OCLCO |d OCLCQ |d KSU |d LEATE |d OCLCO |d OCLCQ |d AU@ |d OCLCO |d UKMGB |d OCLCQ |d S2H |d OCLCO |d LVT |d OCLCA |d OPELS |d OCLCO |d FEM |d OCLCQ | ||
| 015 | |a GBB6G6393 |2 bnb | ||
| 016 | 7 | |a 018091425 |2 Uk | |
| 019 | |a 960030262 |a 960277773 |a 962434234 |a 968035602 |a 969058490 |a 1229432531 | ||
| 020 | |a 9780128027011 |q (electronic bk.) | ||
| 020 | |a 0128027010 |q (electronic bk.) | ||
| 020 | |z 9780128026861 |q (hardcover) | ||
| 020 | |z 0128026863 |q (hardcover) | ||
| 035 | |a (OCoLC)959618098 |z (OCoLC)960030262 |z (OCoLC)960277773 |z (OCoLC)962434234 |z (OCoLC)968035602 |z (OCoLC)969058490 |z (OCoLC)1229432531 | ||
| 050 | 4 | |a RC387.5 | |
| 060 | 4 | |a 2017 B-071 | |
| 060 | 4 | |a WL 354 | |
| 072 | 7 | |a MED |x 056000 |2 bisacsh | |
| 082 | 0 | 4 | |a 617.4810443 |2 23 |
| 245 | 0 | 0 | |a New therapeutics for traumatic brain injury : |b prevention of secondary brain damage and enhancement of repair and regeneration / |c edited by Kim A. Heidenreich. |
| 264 | 1 | |a London : |b Academic Press is an imprint of Elsevier, |c [2017] | |
| 264 | 4 | |c �2017 | |
| 300 | |a 1 online resource (xxv, 325 pages) : |b illustrations (some color) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a text file | ||
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | 0 | |t Part I: Interventional therapies for TBI previously or currently in phase 3 clinical trials. Why did the phase III clinical trials for progesterone in TBI fail? An analysis of three potentially critical factors / |r D.G. Stein, R.B. Howard, I. Sayeed -- |t Hypothermia for traumatic brain injury: current evidence and future directions / |r H. Mtaweh, D. Simon, M.J. Bell -- |t The future of TBI: hyperbaric oxygen as a primary therapeutic approach / |r B. Miskin, L.A. Fox -- |t Part II: Repurposing FDA approved drugs for TBI treatment. Erythropoietin and its derivatives: mechanisms of neuroprotection and challenges in clinical translation / |r T. Bogoslovsky, J.D. Bernstock, K. Kenney, C. Moore, R. Diaz-Arrastia -- |t Atorvastatin in the treatment of traumatic brain injury / |r A.N. Sen, S.P. Gopinath, C.S. Robertson -- |t The application of glibenclamide in traumatic brain injury / |r D.S. Hersh, J.M. Simard, H.M. Eisenberg -- |t Perispinal etanercept for traumatic brain injury / |r E. Tobinick, H. Rodriguez-Romanacce, R. Kinssies, N. Kim -- |t Part III: Interventional drugs for TBI in phase 1-2 clinical trials. Nitric oxide synthase inhibitors in traumatic brain injury / |r R. Schinzel, F. Tegtmeier -- |t Management of paroxysmal sympathetic hyperactivity after traumatic brain injury / |r L.D. Wilson, T.C. Leath, M.B. Patel -- |t Part IV: Interventional drugs for TBI in preclinical development. The use of estrogen for the treatment of traumatic brain injury / |r W.J. Hubbard, I.H. Chaudry -- |t Voltage-gated calcium channel blockers for the treatment of traumatic brain injury / |r G.G. Gurkoff, K. Shahlaie, B.G. Lyeth, R.F. Berman -- |t 5-lipoxygenase-activating protein inhibitors: promising drugs for treating acute and chronic neuroinflammation following brain injury / |r K.A. Heidenreich, C.E. Corser-Jensen -- |t Carbonyl scavenging as an antioxidant neuroprotective strategy for acute traumatic brain injury / |r J.E. Cebak, I.N. Singh, J.A. Wang, R.L. Hill, J.R. Kulbe, E.D. Hall -- |t TrkB receptor agonist 7,8-Dihydroxyflavone and its therapeutic potential for traumatic brain injury / |r J. Romeika, M. Wurzelmann, D. Sun -- |t Ceftriaxone treatment of TBI / |r M.Q. Hameed, A. Rotenberg -- |t Part V: Drugs for TBI rehabilitation. Memantine: a safe and tolerable NMDA antagonist with potential benefits in traumatic brain injury / |r M.A. Keiski -- |t Interventional drugs for TBI Rehabilitation of cognitive impairment: the cholinesterase inhibitor rivastigmine / |r M.A. Hernandez-Tejada, O. Brawman-Mintzer -- |t Docosahexaenoic acid and omega 3 fatty acids / |r M.E. Schober -- |t Treatment of mood disorders following traumatic brain injury / |r H.L. Lin, R.E. Jorge |
| 520 | |a "New Therapeutics for Traumatic Brain Injury: Prevention of Secondary Brain Damage and Enhancement of Repair and Regeneration explores traumatic brain injury (TBI), a major cause of death and disability throughout the world. The delayed nature of the secondary injury phase suggests that there is a therapeutic window for pharmacological interventions or other approaches to prevent progressive tissue damage and improve functional outcomes. It is now apparent that therapeutic interventions should entail both protective and repair/regeneration strategies depending on the phase of brain injury. This book describes emerging experimental strategies for the treatment of TBI, including new anti-inflammatory or anti-apoptotic therapeutics that limit brain damage, and novel or repurposed drugs that enhance repair or regeneration of the brain after injury"--Publisher's description | ||
| 588 | 0 | |a Online resource; title from electronic title page (ScienceDirect viewed March 27, 2018). | |
| 650 | 0 | |a Brain damage |x Treatment. | |
| 650 | 0 | |a Brain damage |x Rehabilitation. | |
| 650 | 0 | |a Brain |x Wounds and injuries |x Complications. | |
| 650 | 1 | 2 | |a Brain Injuries, Traumatic |x drug therapy |0 (DNLM)D000070642Q000188 |
| 650 | 1 | 2 | |a Brain Injuries, Traumatic |x complications |0 (DNLM)D000070642Q000150 |
| 650 | 2 | 2 | |a Brain |x drug effects |0 (DNLM)D001921Q000187 |
| 650 | 2 | 2 | |a Clinical Trials as Topic |0 (DNLM)D002986 |
| 650 | 6 | |a Cerveau |0 (CaQQLa)201-0011413 |x L�esions et blessures |0 (CaQQLa)201-0011413 |x Traitement. |0 (CaQQLa)201-0377521 | |
| 650 | 6 | |a Cerveau |x L�esions et blessures |x Complications et s�equelles. |0 (CaQQLa)201-0272348 | |
| 650 | 7 | |a MEDICAL |x Neurology. |2 bisacsh | |
| 650 | 7 | |a Brain damage |x Treatment. |2 fast |0 (OCoLC)fst00837745 | |
| 650 | 7 | |a Brain |x Wounds and injuries |x Complications. |2 fast |0 (OCoLC)fst00837695 | |
| 650 | 7 | |a Brain damage |x Rehabilitation. |2 fast |0 (OCoLC)fst00837740 | |
| 655 | 4 | |a Internet Resources. | |
| 700 | 1 | |a Heidenreich, Kim A., |e editor. | |
| 776 | 0 | 8 | |i Print version: |t New therapeutics for traumatic brain injury. |d Amsterdam ; Boston : Elsevier/Academic Press, [2017] |z 9780128026861 |w (DLC) 2016942110 |w (OCoLC)971597802 |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780128026861 |z Texto completo |